The Pregnane X Receptor and Indole-3-Propionic Acid Shape the Intestinal Mesenchyme to Restrain Inflammation and Fibrosis

• Published in: Cellular and molecular gastroenterology and hepatology Vol. 15; no. 3; pp. 765 - 795
• Main Authors: Flannigan, Kyle L., Nieves, Kristoff M., Szczepanski, Holly E., Serra, Alex, Lee, Joshua W., Alston, Laurie A., Ramay, Hena, Mani, Sridhar, Hirota, Simon A.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.01.2023; Elsevier
• Subjects: Animals; Colitis, Ulcerative - pathology; Crohn Disease - pathology; Fibroblasts; Fibrosis; Indoles; Inflammation - pathology; Intestinal Fibrosis; Intestines - pathology; Mice; Microbiota; Original Research; Pregnane X Receptor; Pregnane X Receptor - genetics; CSF3; CXCL9; TNFα; CSF2; CXCL8; LP; NR1I2; SPF; CXCL1; IBD; PXR; CXCL2; Intestinal Fibrosis; LPS; UC; NF-κB; Microbiota; GM-CSF; IL1b; ABX; Fibroblasts; WT; GF; Col1a2; IFNγ; PBS; CD; Col3a1; Col1a1; DSS; G-CSF; 4-OHT; MMP; IL5; Cyp3a11; αSMA; TGFβ; PCN; IPA; Pregnane X Receptor
• ISSN: 2352-345X; 2352-345X
• DOI: 10.1016/j.jcmgh.2022.10.014

Fibrosis is a common complication of inflammatory bowel diseases (IBDs). The pregnane X receptor (PXR) (encoded by NR1I2) suppresses intestinal inflammation and has been shown to influence liver fibrosis. In the intestine, PXR signaling is influenced by microbiota-derived indole-3-propionic acid (IPA). Here, we sought to assess the role of the PXR in regulating intestinal inflammation and fibrosis. Intestinal inflammation was induced using dextran sulfate sodium (DSS). Fibrosis was assessed in wild-type (WT), Nr1i2-/-, epithelial-specific Nr1i2-/-, and fibroblast-specific Nr1i2-/- mice. Immune cell influx was quantified by flow cytometry and cytokines by Luminex. Myofibroblasts isolated from WT and Nr1i2-/- mice were stimulated with cytomix or lipopolysaccharide, and mediator production was assessed by quantitative polymerase chain reaction and Luminex. After recovery from DSS-induced colitis, WT mice exhibited fibrosis, a response that was exacerbated in Nr1i2-/- mice. This was correlated with greater neutrophil infiltration and innate cytokine production. Deletion of the PXR in fibroblasts, but not the epithelium, recapitulated this phenotype. Inflammation and fibrosis were reduced by IPA administration, whereas depletion of the microbiota exaggerated intestinal fibrosis. Nr1i2-deficient myofibroblasts were hyperresponsive to stimulation, producing increased levels of inflammatory mediators compared with WT cells. In biopsies from patients with active Crohn’s disease (CD) and ulcerative colitis (UC), expression of NR1I2 was reduced, correlating with increased expression of fibrotic and innate immune genes. Finally, both CD and UC patients exhibited reduced levels of fecal IPA. These data highlight a role for IPA and its interactions with the PXR in regulating the mesenchyme and the development of inflammation and fibrosis, suggesting microbiota metabolites may be a vital determinant in the progression of fibrotic complications in IBD.